none7noneLeoncini L; Delsol G; Gascoyne RD; Harris NL; Pileri SA; Piris MA; Stein H.Leoncini L; Delsol G; Gascoyne RD; Harris NL; Pileri SA; Piris MA; Stein H
Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse ...
Background and Objectives. The REAL/WHO classification constitutes a new tool for the better underst...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
The generic term aggressive B-cell lymphoma includes a variety of entities, each with particular dia...
Classification and proper treatment of extranodal lymphoma is hindered by the diversity of lymphoma ...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
ackground and Objectives. The REAL/WHO classification constitutes a new tool for the better understa...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a c...
B-cell lymphomas encompass a large number of disease entities clinically ranging from indolent to ag...
第58届美国血液学会(ASH)年会有许多B细胞淋巴瘤临床研究结果,现重点介绍会议中关于弥漫大B细胞淋巴瘤和套细胞淋巴瘤的最新研究进展。In the 58th American Society of H...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
Lymphomas are malignant neoplasms characterized by the proliferation of cells native to the lympoid ...
Indolent nonfollicular B-cell lymphoma (INFBCL) has been classified in the World Health Organization...
Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse ...
Background and Objectives. The REAL/WHO classification constitutes a new tool for the better underst...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
The generic term aggressive B-cell lymphoma includes a variety of entities, each with particular dia...
Classification and proper treatment of extranodal lymphoma is hindered by the diversity of lymphoma ...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
ackground and Objectives. The REAL/WHO classification constitutes a new tool for the better understa...
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a c...
B-cell lymphomas encompass a large number of disease entities clinically ranging from indolent to ag...
第58届美国血液学会(ASH)年会有许多B细胞淋巴瘤临床研究结果,现重点介绍会议中关于弥漫大B细胞淋巴瘤和套细胞淋巴瘤的最新研究进展。In the 58th American Society of H...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
Lymphomas are malignant neoplasms characterized by the proliferation of cells native to the lympoid ...
Indolent nonfollicular B-cell lymphoma (INFBCL) has been classified in the World Health Organization...
Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse ...
Background and Objectives. The REAL/WHO classification constitutes a new tool for the better underst...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...